共 8 条
[1]
Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2009, 27 (31)
:5182-5188
[2]
Chen B, 2007, CLIN OPHTHALMIC ONCO, P581
[3]
Huh WW, 2011, MD ANDERSON SOLID TU, P61, DOI 10.1007/978-1-4419-0374-7_4
[4]
DEVELOPMENTAL ORIGINS OF FUSION-NEGATIVE RHABDOMYOSARCOMAS
[J].
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY: MYOGENESIS,
2011, 96
:33-56
[7]
PROGNOSTIC FACTORS IN 951 NONMETASTATIC RHABDOMYOSARCOMA IN CHILDREN - A REPORT FROM THE INTERNATIONAL RHABDOMYOSARCOMA WORKSHOP
[J].
MEDICAL AND PEDIATRIC ONCOLOGY,
1991, 19 (02)
:89-95